[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Crinetics Pharmaceuticals Inc (CRNX)

Crinetics Pharmaceuticals Inc (CRNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,812,676
  • Shares Outstanding, K 105,440
  • Annual Sales, $ 7,700 K
  • Annual Income, $ -465,320 K
  • EBIT $ -545 M
  • EBITDA $ -556 M
  • 60-Month Beta 0.23
  • Price/Sales 1,145.65
  • Price/Cash Flow N/A
  • Price/Book 6.88

Options Overview Details

View History
  • Implied Volatility 8.46% (-1.56%)
  • Historical Volatility 199.72%
  • IV Percentile 0%
  • IV Rank 0.00%
  • IV High 95.22% on 12/17/25
  • IV Low 8.46% on 07/10/26
  • Expected Move (DTE 6) 1.34 (1.61%)
  • Put/Call Vol Ratio 0.61
  • Today's Volume 1,293
  • Volume Avg (30-Day) 1,444
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 19,055
  • Open Int (30-Day) 4,427
  • Expected Range 82.24 to 84.92

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $-1.23
  • Number of Estimates 6
  • High Estimate $-1.04
  • Low Estimate $-1.35
  • Prior Year $-1.23
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.71 +155.56%
on 06/11/26
83.76 -0.21%
on 07/10/26
+49.26 (+143.53%)
since 06/10/26
3-Month
32.30 +158.76%
on 06/02/26
83.76 -0.21%
on 07/10/26
+44.14 (+111.92%)
since 04/10/26
52-Week
25.83 +223.58%
on 08/08/25
83.76 -0.21%
on 07/10/26
+51.59 (+161.27%)
since 07/10/25

Most Recent Stories

More News
$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX)

NEW YORK , July 9, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of dollars for...

CRNX : 83.58 (-0.05%)
Crinetics Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Crinetics Pharmaceuticals, Inc. - CRNX

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Crinetics Pharmaceuticals...

CRNX : 83.58 (-0.05%)
VRTX : 485.39 (-2.24%)
Vertex’s Crinetics Deal Balances Growth with Integration Risk

Vertex Pharmaceuticals will acquire Crinetics Pharmaceuticals for $10 billion at $85 per share, adding the approved drug PALSONIFY and pipeline candidate Atumelant to expand beyond its cystic fibrosis...

CRSP : 53.35 (-5.31%)
CRNX : 83.58 (-0.05%)
VRTX : 485.39 (-2.24%)
AI stocks sink and drag markets lower worldwide

The roller-coaster ride for AI stocks snapped back down and dragged Wall Street lower

NVDA : 210.96 (+4.03%)
AAPL : 315.32 (-0.28%)
AVGO : 399.97 (-0.28%)
$SPX : 7,575.39 (+0.42%)
CRNX : 83.58 (-0.05%)
MU : 979.30 (-1.24%)
VRTX : 485.39 (-2.24%)
RIVN : 17.48 (-3.53%)
$IUXX : 29,825.11 (+0.33%)
WULF : 21.97 (-5.30%)
SPCX : 145.30 (-4.51%)
INTC : 109.84 (-2.40%)
Stock Indexes Fall as Chip Stocks Sink and Crude Soars

The S&P 500 Index ($SPX ) (SPY ) on Tuesday closed down -0.45%, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down -0.25%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -1.77%. September...

ALK : 49.42 (-1.44%)
SNDK : 1,915.92 (+3.10%)
ADI : 395.65 (+0.51%)
SLB : 47.76 (+1.10%)
RIVN : 17.48 (-3.53%)
TRI : 89.65 (+0.95%)
OXY : 52.89 (+1.13%)
ALAB : 412.97 (-1.07%)
FANG : 183.39 (+0.76%)
STX : 910.34 (+2.28%)
WDC : 582.59 (+0.78%)
AMD : 557.89 (+2.04%)
Stock Indexes Falter as Chip Stocks Tumble

The S&P 500 Index ($SPX ) (SPY ) today is down -0.67%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is down -0.38%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -2.14%. September E-mini S&P futures...

ALK : 49.42 (-1.44%)
SNDK : 1,915.92 (+3.10%)
ADI : 395.65 (+0.51%)
RIVN : 17.48 (-3.53%)
TRI : 89.65 (+0.95%)
ALAB : 412.97 (-1.07%)
STX : 910.34 (+2.28%)
WDC : 582.59 (+0.78%)
AMD : 557.89 (+2.04%)
CTSH : 42.57 (-1.91%)
SPY : 754.95 (+0.43%)
ADSK : 208.45 (-0.06%)
Stock Indexes Fall as Chipmakers Retreat

The S&P 500 Index ($SPX ) (SPY ) today is down -0.19%, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up +0.04%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -1.43%. September E-mini S&P futures...

AMAT : 602.50 (+2.35%)
SNDK : 1,915.92 (+3.10%)
INTU : 274.96 (+0.58%)
ADI : 395.65 (+0.51%)
FISV : 50.45 (-2.32%)
$SOX : 12,967.16 (+0.06%)
RIVN : 17.48 (-3.53%)
TRI : 89.65 (+0.95%)
$IUXX : 29,825.11 (+0.33%)
ASML : 1,797.32 (-0.38%)
ZNU26 : 109-010s (-0.21%)
MSFT : 385.10 (+0.19%)
Shareholder Alert: Ademi LLP investigates whether Crinetics Pharmaceuticals, Inc. is obtaining a Fair Price for Public Shareholders

MILWAUKEE , July 6, 2026 /PRNewswire/ -- Ademi LLP is investigating Crinetics (Nasdaq: CRNX) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

CRNX : 83.58 (-0.05%)
CRNX Stock Alert: Halper Sadeh LLC is Investigating Whether Crinetics Pharmaceuticals, Inc. is Obtaining a Fair Price for its Shareholders

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transaction may contain terms that...

CRNX : 83.58 (-0.05%)
Vertex to Acquire Crinetics Pharmaceuticals

- Crinetics adds potential best-in-class commercialized and Phase 3 endocrinology assets with ~$5 billion peak sales opportunity to Vertex’s portfolio - - ...

CRNX : 83.58 (-0.05%)
VRTX : 485.39 (-2.24%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Weakening short term outlook on maintaining the current direction.

Relative Strength is above 80%. The market is in extreme overbought territory. Beware of a trend reversal.

See More Share

Business Summary

CRINETICS PHARMACEUTICALS is a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for endocrine diseases and endocrine-related tumors. CRINETICS PHARMACEUTICALS is based in SAN DIEGO.

See More

Key Turning Points

3rd Resistance Point 83.88
2nd Resistance Point 83.82
1st Resistance Point 83.70
Last Price 83.58
1st Support Level 83.52
2nd Support Level 83.46
3rd Support Level 83.34

See More

52-Week High 83.76
Last Price 83.58
Fibonacci 61.8% 61.63
Fibonacci 50% 54.80
Fibonacci 38.2% 47.96
52-Week Low 25.83

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.